Kazano (alogliptin/metformin) / Takeda  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kazano (alogliptin/metformin) / Takeda
NCT02508168: Phase 1 Bioavailability Study of SYR-322MET

Completed
1
24
RoW
Alogliptin, Vipidia, Metformin Hydrochloride, Glucophage, SYR-322MET
Takeda
Healthy Volunteers
04/16
04/16

Download Options